As of 2026-01-23, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -3.59 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.22 USD, the upside of Aldeyra Therapeutics Inc is -168.77%.
Based on its market price of 5.22 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 168.77%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.59 - -3.59 | -3.59 | -168.77% |
| P/E | (5.46) - (10.24) | (7.56) | -244.8% |
| DDM - Stable | (5.32) - (18.12) | (11.72) | -324.6% |
| DDM - Multi | (6.34) - (17.16) | (9.30) | -278.1% |
| Market Cap (mil) | 314.04 |
| Beta | 3.08 |
| Outstanding shares (mil) | 60.16 |
| Enterprise Value (mil) | 269.89 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.50% |
| Cost of Debt | 5.00% |
| WACC | 10.15% |